Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2023-02-08 00:00:00 ET · period of report 2023-02-06 · accession 0001209191-23-007827 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-02-08 | 2023-02-06 | VRTX | ALTSHULER DAVID | EVP, CSO, Gbl Research | S - Sale+OE | $306.00 | -1,304 | 69.9K | -2% | -$399.0K |
| D | 2023-02-08 | 2023-02-06 | VRTX | ALTSHULER DAVID | EVP, CSO, Gbl Research | M - OptEx | $187.53 | +1,304 | 69.9K | +2% | +$244.5K |
| D | 2023-02-08 | 2023-02-06 | VRTX | ALTSHULER DAVID | EVP, CSO, Gbl Research | M - OptEx | $0.00 | -1,304 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-06 | S | D | 70 | $302.00 | 69,867 | D | — | — | |
| 2 | Common | Common Stock | 2023-02-06 | S | D | 153 | $309.06 | 68,645 | D | — | — | (F6) Open market sales reported on this line occurred at a weighted average price of $309.06 (range $308.76 to $309.42). (F2) Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2023-02-06 | S | D | 620 | $306.70 | 68,798 | D | — | — | (F5) Open market sales reported on this line occurred at a weighted average price of $306.70 (range $306.32 to $307.25). (F2) Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2023-02-06 | S | D | 349 | $305.08 | 69,418 | D | — | — | (F4) Open market sales reported on this line occurred at a weighted average price of $305.08 (range $304.72 to $305.43). (F2) Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 5 | Common | Common Stock | 2023-02-06 | S | D | 100 | $303.64 | 69,767 | D | — | — | (F3) Open market sales reported on this line occurred at a weighted average price of $303.64 (range $303.37 to $304.27). (F2) Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 6 | Common | Common Stock | 2023-02-06 | M | A | 1,304 | $187.53 | 69,949 | D | — | — | |
| 7 | Common | Common Stock | 2023-02-06 | S | D | 12 | $300.39 | 69,937 | D | — | — | |
| 8 | Derivative | Stock Option (Right to Buy) | 2023-02-06 | M | D | 1,304 | $0.00 | 0 | D | $187.53 · — to 2029-02-05 | 1,304 Common Stock | (F7) Fully vested. |